• In vitro and in vivo efficacy of doxorubicin loaded biodegradable semi-interpenetrating hydrogel implants of poly (acrylic acid)/gelatin for post-surgical tumor treatment. Jaiswal M, Naz F, Dinda AK, Koul V. Biomed Mater. 2013 Aug;8(4):045004. doi: 10.1088/1748-6041/8/4/045004. Epub 2013 May 29.

  • Nanotamoxifen Delivery System: Toxicity Assessment After Oral Administration and Biodistribution Study After Intravenous Delivery of Radiolabeled Nanotamoxifen. Shukla J, Dinda AK, Srivastava AK, Srivastava K, Mittal BR, Bandopadhyaya GP. World J Nucl Med. 2016 Jan-Apr;15(1):7-11. doi: 10.4103/1450-1147.167594.

  • Cell adhesion and proliferation studies on semi-interpenetrating polymeric networks (semi-IPNs) of polyacrylamide and gelatin. Jaiswal M, Koul V, Dinda AK, Mohanty S, Jain KG. J Biomed Mater Res B Appl Biomater. 2011 Aug;98(2):342-50. doi: 10.1002/jbm.b.31857. Epub 2011 Jun 6.

  • Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Naqvi S, Samim M, Abdin M, Ahmed FJ, Maitra A, Prashant C, Dinda AK. Int J Nanomedicine. 2010 Nov 16;5:983-9. doi: 10.2147/IJN.S13244.

  • Characterization and cell material interactions of PEGylated PNIPAAM nanoparticles. Gulati N, Rastogi R, Dinda AK, Saxena R, Koul V. Colloids Surf B Biointerfaces. 2010 Aug 1;79 (1): 164 - 73. doi:10.1016/j.colsurfb.2010.03.049. Epub 2010 Apr 10

Nanotoxicity
  • Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex. Barwal I, Kumar R, Kateriya S, Dinda AK, Yadav SC. Sci Rep. 2016 Nov 22;6:37096. doi:10.1038/srep37096.

  • Novel nanocarrier for oral Hepatitis B vaccine. Dinda AK, Bhat M, Srivastava S, Kottarath SK, Prashant CK. Vaccine. 2016 Jun 8;34(27):3076-81. doi: 10.1016/j.vaccine.2016.04.084. Epub 2016 May 6

  • Biokinetics of ultrafine gold nanoparticles (AuNPs) relating to redistribution and urinary excretion: a long-term in vivo study. Naz F, Koul V, Srivastava A, Gupta YK, Dinda AK. J Drug Target. 2016 Feb 26:1-10. [Epub ahead of print]

  • Cancer Cell Targeting Using Folic Acid/Anti-HER2 Antibody Conjugated Fluorescent CdSe/CdS/ZnS-MPA and CdTe-MSA Quantum Dots. Singh G, Kumar M, Soni U, Arora V, Bansal V, Gupta D, Bhat M, Dinda AK, Sapra S, Singh H. J Nanosci Nanotechnol 2015 Dec;15(12):9382-95.

  • Nanoparticle based tailoring of adjuvant function: the role in vaccine development. Prashant CK, Kumar M, Dinda AK.J Biomed Nanotechnol. 2014 Sep;10(9):2317-31

  • Organically Modified Silica Nanoparticles Interaction with Macrophage Cells: Assessment of Cell Viability on the Basis of Physicochemical Properties. Kumar D, Mutreja I, Keshvan PC, Bhat M, Dinda AK, Mitra S. J Pharm Sci. 2015 Nov;104(11):3943-51. doi: 10.1002/jps.24614. Epub 2015 Aug 21.

  • Intracellular delivery of peptide cargos using iron oxide based nanoparticles: studies on antitumor efficacy of a BCL-2 converting peptide, NuBCP-9. Kumar M, Singh G, Sharma S, Gupta D, Bansal V, Arora V, Bhat M, Srivastava SK, Sapra S, Kharbanda S, Dinda AK, Singh H. Nanoscale. 2014 Nov 6;6(23):14473-83

  • Novel polymeric nanoparticles for intracellular delivery of peptide cargos: antitumor efficacy of the Bcl-2 conversion peptide NuBCP-9. Kumar M, Gupta D, Singh G, Sharma S, Bhatt M, Prashant CK, Dinda AK, Kharbanda S, Kufe D, Singh H. Cancer Res. 2014 Apr 16.

  • Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity. Prashant CK, Bhat M, Srivastava SK, Saxena A, Kumar M, Singh A, Samim M, Ahmad FJ, Dinda AK. Int J Nanomedicine. 2014 Feb 12;9:937-50. doi: 10.2147/IJN.S55892. eCollection 2014.

  • Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model. Ali M, Afzal M, Verma M, Bhattacharya SM, Ahmad FJ, Samim M, Abidin MZ, Dinda AK. Parasitol Res. 2014 Feb;113(2):681-91. doi: 10.1007/s00436-013-3696-5. Epub 2013 Dec 24.

  • Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences. Ali M, Afzal M, Kaushik U, Bhattacharya SM, Ahmad FJ, Dinda AK. J Drug Target. 2014 Jan;22(1):1-13. doi: 10.3109/1061186X.2013.832766.  Epub 2013 Sep 5.

  • Bi-layer composite dressing of gelatin nanofibrous mat and poly vinyl alcohol hydrogel for drug delivery and wound healing application: in-vitro and in-vivo studies. Jaiswal M, Gupta A, Agrawal AK, Jassal M, Dinda AK, Koul V. J Biomed Nanotechnol. 2013 Sep;9(9):1495-508.

  • Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi. Ali M, Afzal M, Verma M, Misra-Bhattacharya S, Ahmad FJ, Dinda AK. Parasitol Res. 2013 Aug;112(8):2933-43. doi: 10.1007/s00436-013-3466-4. Epub 2013 Jul 5.

  • Nanopharmaceuticals to target antifilarials: a comprehensive review. Ali M, Afzal M, Bhattacharya SM, Ahmad FJ, Dinda AK. Expert Opin Drug Deliv. 2013 May;10(5):665-78. doi: 10.1517/17425247.2013.771630. Epub 2013 Feb 22. Review.

  • Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Kumar M, Singh G, Arora V, Mewar S, Sharma U, Jagannathan NR, Sapra S, Dinda AK, Kharbanda S, Singh H. Int J Nanomedicine. 2012;7:3503-16. doi: 10.2147/IJN.S32694. Epub 2012 Jul 6.

  • Curcumin loaded organically modified silica (ORMOSIL) nanoparticle; a novel agent for cancer therapy. Dinda AK, Prashant CK, Naqvi S, Unnithan J; Samim M, Maitra A. Journal: Int. J. of Nanotechnology, 2012 Vol.9, No.10/11/12, pp.862 - 871

  • Synthesis and characterization of gold nanorods and their application for photothermal cell damage. Samim M, Prashant CK, Dinda AK, Maitra AN, Arora I. Int J Nanomedicine. 2011;6:1825-31. doi: 10.2147/IJN.S11600. Epub 2011 Aug 31.

  • Polycaprolactone diacrylate crosslinked biodegradable semi-interpenetrating networks of polyacrylamide and gelatin for controlled drug delivery. Jaiswal M, Dinda AK, Gupta A, Koul V. Biomed Mater. 2010 Dec;5(6):065014. doi: 10.1088/1748-6041/5/6/065014. Epub 2010 Nov 15.

  • Impact of magnetic nanoparticles in biomedical applications. Naqvi S, Samim M, Dinda AK, Iqbal Z, Telagoanker S, Ahmed FJ, Maitra A. Recent Pat Drug Deliv Formul. 2009 Jun;3(2):153-61.

  • Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Changez M, Varshney M, Chander J, Dinda AK. Colloids Surf B Biointerfaces. 2006 Jun 1;50(1):18-25. Epub 2006 Mar 29.

  • Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Changez M, Chander J, Dinda AK. Colloids Surf B Biointerfaces. 2006 Mar 1; 48 (1): 58-66. Epub 2006 Feb 21

Nanomedicine

Call

T: 011 - 26593412  F: 011 - 26588663

Address

Room No 1084, 1st Floor,

Dept. of Pathology, AIIMS